| Not Yet Recruiting | Denosumab Strategy for Liver Cancer With Bone Metastases NCT07537972 | Tongji Hospital | Phase 2 |
| Recruiting | Registry for Bone Metastases NCT07391410 | Memorial Sloan Kettering Cancer Center | — |
| Recruiting | Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases NCT07202273 | University of Utah | N/A |
| Not Yet Recruiting | Validation of Whole Body PET/CT Foundation Model NCT07196995 | Shanghai 6th People's Hospital | — |
| Not Yet Recruiting | Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy NCT07185958 | Aalborg University Hospital | — |
| Recruiting | BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe NCT06480955 | Cardiovascular and Interventional Radiological Society of Europe | — |
| Recruiting | Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases NCT07146074 | Cancer Research Antwerp | N/A |
| Enrolling By Invitation | EXercise Enhancement After RadioTherapy for Bone Metastases NCT06470503 | University Health Network, Toronto | N/A |
| Enrolling By Invitation | Risk Model for Metastasis Detection of Neuroblastoma NCT06703944 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Recruiting | Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma NCT06524843 | Costantino Errani | — |
| Completed | EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy NCT06376682 | Quantum Surgical | N/A |
| Recruiting | Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer w NCT06538896 | Zhejiang Cancer Hospital | Phase 2 |
| Not Yet Recruiting | A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases NCT06544668 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | — |
| Not Yet Recruiting | Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study NCT06487026 | EpiSonica | N/A |
| Withdrawn | MR Guided Focused Ultrasound vs Radiotherapy for Palliative Pain Tx in Bone Metastases NCT05250687 | Stanford University | N/A |
| Recruiting | Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of P NCT06918860 | Costantino Errani | — |
| Active Not Recruiting | Management of Bone Metastases NCT06713941 | Hospices Civils de Lyon | — |
| Recruiting | clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases NCT06392217 | Fudan University | — |
| Unknown | Efficacy of a Herbal Formula for Bone Metastases NCT06023420 | Chinese University of Hong Kong | Phase 1 / Phase 2 |
| Recruiting | A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative R NCT06065449 | M.D. Anderson Cancer Center | Phase 3 |
| Unknown | Diagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT Simulation NCT06235034 | British Columbia Cancer Agency | N/A |
| Unknown | [68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors NCT06455722 | First Affiliated Hospital of Fujian Medical University | EARLY_Phase 1 |
| Unknown | TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer NCT05730972 | The Third Affiliated hospital of Zhejiang Chinese Medical University | N/A |
| Recruiting | Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases: A Pivotal NCT06487013 | EpiSonica | N/A |
| Not Yet Recruiting | Short Versus Long Intramedullary Nails in the Treatment of Proximal Femur Metastasis. NCT05969470 | National Taiwan University Hospital | N/A |
| Recruiting | Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study NCT06189079 | Istituto Ortopedico Rizzoli | — |
| Unknown | Primary Lesion Treatment for Bone Metastases NCT05665790 | Shanghai 6th People's Hospital | N/A |
| Unknown | Local Treatment for Bone Metastases NCT05665439 | Shanghai 6th People's Hospital | N/A |
| Not Yet Recruiting | Regional Database for Collecting Clinical-biological and Imaging Data "Secondary Bone Oncology and Bone Locali NCT05495802 | University Hospital, Lille | — |
| Unknown | Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitouri NCT05597215 | Assiut University | — |
| Withdrawn | A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors NCT04791228 | Children's National Research Institute | Phase 2 |
| Completed | Pain Relief in Symptomatic Bone Metastases With Adjuvant Hyperthermia MR Guided HIFU NCT05167669 | Sana Boudabbous | N/A |
| Terminated | A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese M NCT05301062 | Bayer | — |
| Withdrawn | A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy NCT03612466 | Albert Einstein College of Medicine | Phase 1 |
| Unknown | Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases NCT05466812 | Peking Union Medical College Hospital | Phase 4 |
| Recruiting | Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases NCT05406063 | Kantonsspital Winterthur KSW | N/A |
| Recruiting | Metastatic Pathologic Fractures, Short Term Results NCT05825456 | Ankara University | — |
| Recruiting | SBRT Technique Implementation for Spinal Metastases Irradiation NCT07429422 | Institute of Oncology Ljubljana | N/A |
| Unknown | Ablation and Cementoplasty for Painful Bone Lesions NCT04635137 | University of Calgary | N/A |
| Unknown | Ankle Arthrodesis Nail for 2-level Pathologic Tibial Fracture NCT04940754 | Orthopaedie Zentrum Zuerich | N/A |
| Completed | Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT NCT05614518 | HTA Co., Ltd. | Phase 3 |
| Unknown | Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the NCT05381077 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Unknown | Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONE NCT04720391 | European Institute of Oncology | — |
| Recruiting | Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast C NCT04947280 | Fudan University | Phase 1 / Phase 2 |
| Unknown | Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief NCT04177056 | Hamilton Health Sciences Corporation | N/A |
| Unknown | CTC in Lung Caner Patients With Bone Metastases NCT04568291 | Shanghai 6th People's Hospital | N/A |
| Withdrawn | External Beam Radiation Therapy Post Surgery in Patients With Lower Extremity Bone Metastases Randomized Effic NCT04109937 | Sunnybrook Health Sciences Centre | N/A |
| Completed | Retrospective Case Series of COVID19+ Patients Undergoing Orthopedic Surgery NCT05881343 | Istituto Ortopedico Rizzoli | — |
| Completed | Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors NCT04812509 | Mabwell (Shanghai) Bioscience Co., Ltd. | Phase 3 |
| Active Not Recruiting | Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases NCT04307914 | UMC Utrecht | N/A |
| Unknown | Evaluation of an Accelerated Body-whole Bone CT Procedure With the CZT "VERITON-CT ™" Camera NCT04157166 | Central Hospital, Nancy, France | N/A |
| Unknown | Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases NCT04167605 | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | — |
| Unknown | Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases NCT04159376 | Tel-Aviv Sourasky Medical Center | N/A |
| Completed | Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases. NCT04080271 | Assiut University | — |
| Unknown | Radioiodine-avid Bone Metastases From Thyroid Cancer Without Structural Abnormality NCT04141306 | Hospices Civils de Lyon | — |
| Active Not Recruiting | Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease NCT05101824 | Gitte Fredberg Persson MD PhD | N/A |
| Completed | Exercise Prescription in Patients With Bone Metastases NCT03979118 | University of Dublin, Trinity College | — |
| Terminated | Cryoablation of Bone Metastases From Endocrine Tumors NCT03986593 | Instituto do Cancer do Estado de São Paulo | N/A |
| Unknown | A Prospective Randomized Trial of High Dose Versus Standard Dose Stereotactic Radiotherapy for Pain Control in NCT04063254 | National Taiwan University Hospital | Phase 2 |
| Unknown | Reduction of Pain Symptoms With Stereotactic Radiotherapy on Bone Metastases NCT03597984 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Unknown | To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors NCT04550949 | Qilu Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis NCT04310410 | UMC Utrecht | Phase 1 / Phase 2 |
| Active Not Recruiting | Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MED NCT03795207 | Institut Cancerologie de l'Ouest | Phase 2 |
| Recruiting | Post-Op Pain Control for Prophylactic Intramedullary Nailing. NCT03823534 | St. Louis University | Phase 3 |
| Unknown | Pain Phenotyping of Patients With Bone Cancer Pain NCT03908853 | University of Copenhagen | — |
| Terminated | Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bo NCT03869762 | Cancer Trials Ireland | Phase 2 |
| Active Not Recruiting | 9-ING-41 in Patients With Advanced Cancers NCT03678883 | Actuate Therapeutics Inc. | Phase 2 |
| Completed | Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets NCT03661892 | University of Arizona | EARLY_Phase 1 |
| Completed | Identification and Characterization of Predictive Factors of Onset of Bone Metastases in Cancer Patients NCT03895216 | Istituto Ortopedico Rizzoli | — |
| Completed | Is Bone Scintigraphy Necessary in cT1N0M0 GGO Non-Small Cell Lung Cancer? (ECTOP-1006) NCT03689439 | Fudan University | — |
| Unknown | Single frActIoN eighT Gray Palliative Radiotherapy With Modulated Intensity for Pain Reduction NCT03554135 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Completed | Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIV NCT03669523 | Centre Hospitalier Annecy Genevois | Phase 2 |
| Active Not Recruiting | Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases NCT03143322 | UNICANCER | N/A |
| Unknown | Safety, Tolerability and PK/PD of JMT103 in Patients With Bone Metastases From Tumors NCT03550508 | Shanghai JMT-Bio Inc. | Phase 1 |
| Terminated | Radiosurgical Hypophysectomy for Bone Metasteses Pain NCT03377517 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Withdrawn | Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases NCT03479151 | Institute of Cancer Research, United Kingdom | N/A |
| Completed | Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Pa NCT03924609 | Peking University People's Hospital | — |
| Unknown | Evaluation of the Ability of CT-based Finite Element Analysis (CTFEA) to Predict Fractures in Patients With Me NCT03453905 | Tel-Aviv Sourasky Medical Center | N/A |
| Recruiting | Radiotherapy Treatments for Neoplasms of the Limbs NCT06335251 | European Institute of Oncology | — |
| Enrolling By Invitation | LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology NCT03244020 | Massachusetts General Hospital | Phase 4 |
| Terminated | Merestinib on Bone Metastases in Subjects With Breast Cancer NCT03292536 | University of Utah | Phase 1 |
| Completed | Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patient NCT03336983 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Phase 2 |
| Recruiting | Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method? NCT03261544 | Duke University | — |
| Unknown | Short Course Radiation Therapy in Palliative Treatment of Complicated Bone Metastases NCT03503682 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Unknown | The Combination Therapy With Ra-223 and Enzalutamide NCT03305224 | Taro Iguchi, MD, PHD | Phase 2 |
| Unknown | Circulating Osteocalcin-positive Cells in Breast Cancer Bone Metastasis NCT03814811 | Seoul National University Hospital | — |
| Unknown | MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases NCT03106675 | Turku University Hospital | N/A |
| Completed | First-In Man (FIM) Study MR-Linac NCT03284619 | Nucletron Operations BV | N/A |
| Completed | Health-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Ra NCT04995614 | Radboud University Medical Center | — |
| Terminated | Lazanda in Cancer Patients Receiving Palliative Radiation NCT03071744 | Joseph Ma | Phase 2 |
| Completed | MRgFUS Versus EBRT in Patients With Metastatic Non-spinal Bone Disease NCT03404362 | University of Roma La Sapienza | N/A |
| Terminated | uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cance NCT02964988 | Rigshospitalet, Denmark | Phase 2 |
| Terminated | Evaluation of the Performance of Y-STRUT® Medical Device to Strengthen Pre-fractural Tumour-induced Lesions at NCT03579212 | Hyprevention | — |
| Completed | Double-bed SPECT/CT for Bone Scintigraphy in Initial Staging of Cancer Patients NCT03353090 | University Hospital, Brest | — |
| Unknown | Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases NCT02880943 | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | Phase 1 / Phase 2 |
| Completed | Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041 NCT02826382 | Five Eleven Pharma, Inc. | EARLY_Phase 1 |
| Completed | 18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients. NCT02969564 | Valentina Garibotto | — |
| Terminated | Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeleta NCT02715856 | M.D. Anderson Cancer Center | N/A |
| Terminated | Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases NCT02582749 | Ajjai Alva, MD | Phase 2 |
| Completed | Surgical Treatment of Long Bone Metastases NCT03188926 | Istituto Ortopedico Rizzoli | — |
| Completed | The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures NCT06153576 | Centre Hospitalier Universitaire de Nice | — |
| Completed | Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGO NCT04516707 | Institut du Cancer de Montpellier - Val d'Aurelle | — |
| Completed | Comparing Immobilisation Shells in Cranial Radiotherapy NCT02599142 | Royal Marsden NHS Foundation Trust | N/A |
| Completed | Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223 NCT03223727 | The Netherlands Cancer Institute | — |
| Completed | Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With R NCT03223597 | The Netherlands Cancer Institute | — |
| Active Not Recruiting | Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patien NCT02226276 | City of Hope Medical Center | N/A |
| Completed | Randomized Trial Comparing Conventional Radiotherapy With Stereotactic Radiotherapy in Patients With Bone Meta NCT02364115 | UMC Utrecht | N/A |
| Completed | Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer NCT02410044 | iOMEDICO AG | — |
| Completed | A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diag NCT02163226 | M.D. Anderson Cancer Center | Phase 2 / Phase 3 |
| Active Not Recruiting | Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks NCT02051218 | Swiss Cancer Institute | Phase 3 |
| Terminated | Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases NCT01767935 | Wake Forest University Health Sciences | N/A |
| Completed | Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS NCT02376322 | Santa Casa de Porto Alegre | Phase 2 |
| Completed | A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine NCT01992016 | University of Colorado, Denver | N/A |
| Withdrawn | MRI Guided HIFU for Palliation of Painful Skeletal Metastases in Children NCT02616016 | The Hospital for Sick Children | N/A |
| Completed | MR-HIFU for Bone Metastases NCT01964677 | Institute of Cancer Research, United Kingdom | N/A |
| Recruiting | National Database of Bone Metastases NCT06367491 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | — |
| Active Not Recruiting | FDG PET/CT in Breast Cancer Bone Mets NCT01996046 | University of Pennsylvania | — |
| Completed | Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate NCT01807065 | City of Hope Medical Center | Phase 2 |
| Recruiting | Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort NCT02356497 | UMC Utrecht | — |
| Completed | Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases NCT01429493 | University Hospital, Ghent | Phase 2 / Phase 3 |
| Completed | Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma NCT01345019 | Amgen | Phase 3 |
| Completed | Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostat NCT01599793 | University of Chicago | Phase 2 |
| Completed | Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009 NCT01669499 | UMC Utrecht | Phase 3 |
| Active Not Recruiting | Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases NCT01470105 | Memorial Sloan Kettering Cancer Center | — |
| Terminated | Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases NCT01417403 | Virginia Commonwealth University | Phase 1 |
| Completed | Rapid Radiation Therapy for Painful Osseous Metastatic Disease NCT01391234 | University of Virginia | N/A |
| Unknown | Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adeno NCT02810262 | Hospices Civils de Lyon | — |
| Completed | Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy NCT01248585 | NCIC Clinical Trials Group | Phase 3 |
| Completed | QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas NCT01231347 | NantCell, Inc. | Phase 3 |
| Completed | Imaging of Prostate and Breast Cancer Bone Metastases Using Magnetic Resonance Imaging and Nuclear Medicine Te NCT01339780 | Turku University Hospital | N/A |
| Completed | F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases NCT01254929 | Seattle Nuclear Medicine | — |
| Completed | Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology NCT01696760 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Palliation: the Effect of Education on Pain NCT01358539 | University Medical Center Groningen | Phase 3 |
| Completed | A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cance NCT01106352 | Bayer | Phase 1 / Phase 2 |
| Completed | Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and Exte NCT01091883 | InSightec | N/A |
| Completed | Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients NCT00956163 | National Cancer Institute (NCI) | EARLY_Phase 1 |
| Completed | Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 21 NCT01085565 | InSightec | Phase 2 |
| Completed | BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease NCT01070485 | Bayer | Phase 2 |
| Completed | Open Label Extension In Cancer Patients NCT00830180 | Pfizer | Phase 2 |
| Terminated | ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain NCT00981578 | InSightec | N/A |
| Completed | Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastas NCT01144481 | University Health Network, Toronto | — |
| Completed | Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Dia NCT00824213 | University of British Columbia | — |
| Unknown | F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets NCT00882609 | American College of Radiology - Image Metrix | Phase 3 |
| Completed | A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the NCT00958477 | Merck KGaA, Darmstadt, Germany | Phase 1 |
| Completed | Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metas NCT00762346 | Sun Yat-sen University | Phase 4 |
| Terminated | A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases NCT00757757 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bispho NCT00765687 | Sun Yat-sen University | Phase 4 |
| Completed | A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer Wit NCT00699751 | Bayer | Phase 3 |
| Completed | Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy NCT00688038 | M.D. Anderson Cancer Center | Phase 4 |
| Completed | ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain NCT00656305 | InSightec | N/A |
| Completed | Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis NCT00566618 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only M NCT00429507 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | MR Guided Focused Ultrasound Surgery in the Treatment of Pain From Bone Tumors w/ the ExAblate 2000 Strappable NCT03547557 | InSightec | N/A |
| Completed | Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasi NCT00524849 | Fudan University | Phase 2 / Phase 3 |
| Completed | Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple M NCT00330759 | Amgen | Phase 3 |
| Completed | MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors NCT00350233 | InSightec | Phase 1 |
| Completed | Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial) NCT00503178 | University Hospital, Ghent | Phase 2 |
| Completed | Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer NCT00321620 | Amgen | Phase 3 |
| Completed | A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects NCT00321464 | Amgen | Phase 3 |
| Completed | Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation NCT00264420 | The Cleveland Clinic | Phase 1 |
| Completed | BAY88-8223, Does Response Study in HRPC Patients NCT00667199 | Bayer | Phase 2 |
| Unknown | Concurrent Xeloda and Radiotherapy for Bone Metastases NCT00192777 | Rambam Health Care Campus | Phase 2 |
| Completed | Bone Response in Metastatic Breast Cancer Involving Bones NCT00420433 | M.D. Anderson Cancer Center | — |
| Completed | A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Ca NCT00156884 | Alberta Health services | Phase 2 |
| Completed | BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy NCT00040755 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer NCT00019695 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Palliative Radiotherapy for Bone Metastases: Single Versus Multiple Fractions. NCT00858741 | Marilia Medicine School | Phase 3 |